Navigation Links
Common PTSD Drug is No More Effective Than Placebo

Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a study// led by researchers at the San Francisco VA Medical Center.

“There was no benefit at all, and there were several adverse side effects,” says lead author Thomas Neylan, MD, medical director of the PTSD treatment program at SFVAMC. “People with symptoms of PTSD should probably stay away from this drug and others of its type.”

The study appears in the December 1, 2006 issue of the American Journal of Psychiatry.

Guanfacine belongs to a class of medications known as alpha-2 agonists, which lower the brain’s supply of the neurotransmitter norepinephrine. Neurotransmitters are chemicals that transmit electrical signals between nerve cells. They are responsible for many aspects of behavior.

“Norepinephrine is released in the brain during states of excited arousal, and PTSD is associated with that state – patients startle easily, have trouble sleeping, and are hypervigilant and anxious,” explains Neylan, who is also an associate professor of psychiatry at the University of California, San Francisco.

Guanfacine and clonidine, another alpha-2 agonist, are commonly prescribed for PTSD symptoms. “There are at least 20 peer-reviewed articles published in the field of PTSD that recommend drugs which lower norepinephrine,” Neylan says. “However, ours was the first randomized, controlled study of alpha-2 agonists for symptoms of PTSD.”

The double-blind study compared the effects of guanfacine and an identical looking placebo pill on 63 male and female veterans at four VA medical centers in California and Hawaii. Twenty-nine participants were randomly assigned to take weekly doses of the drug, and 34 were assigned the placebo, for eight weeks.

At the end of the study, the effect of guanfacine on PTSD symptoms was “zero,” and there were no d
'"/>




Page: 1 2

Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Common Cold Found to Fight Cancer Cells
11. Side Effects Of Some Common Drugs

Post Your Comments:
(Date:12/4/2009)...swire/ -- Herpes zoster, also known as shingles, i...d against chicken pox, according to a Kaiser Perma...c Infectious Diseases Journal. ,, The study, t...ords to identify more than 170,000 children vaccin... 2002 to 2008 in Kaiser Permanente,s Southern Cali...
(Date:12/3/2009)... increase of more than 15 percent since 2007, the ... in its history, but also as a sign of the organiz...eriencing a decline in membership due to the strug...zations across the nation are suffering significan...owth, signaling that physicians see considerable v...
(Date:12/3/2009)...wswire/ -- The development of University Medical C... milestone today with a "topping out" ceremony, ma...t the new hospital that will replace University Me...ttp://www.newscom.com/cgi-bin/prnh/20091203/NY2097..., tradition in which a steel beam carrying an ever...
(Date:12/3/2009)...e-Asia/ -- Long believed to provide a variety of,h...ingredients in global,cuisine, has seen increased ... The timing of this ginger demand increase coincid...ressures in a way that has speculators wondering a...eria over garlic. Garlic, also,believed to have fl...
(Date:12/3/2009)...SNewswire/ -- The American Association of Homes an...te for passing Sen. Michael Bennet,s (D-Colo.) ame...anteed benefits, and strengthens Medicare by keepi...ver tsunami of retiring baby boomers fast approach...tion currently before Congress to address Medicare...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2
...ABT ),today announced the start of SPIRIT Small Ve...f the XIENCE V(TM) Everolimus Eluting Coronary Ste...ysicians an option for treating,coronary artery di...the United States, where it quickly,became the mar...
...where data doesn,t match WHO reports , , W...ion fewer children are immunized against diphtheri...ividual nations and World Health Organization/UNIC...ashington in Seattle researchers calculated that 5...
...ial tasks, including mental rotation, which is the... if rotated in space. Now, a University of Iowa st...lity and the structure of the parietal lobe, the b...ng proportionally thicker cortexes or "grey matter...
...Ltd. announced today that it has settled all ongoi...ne tablets, the generic version of Schering-Plough...ms of the settlement, Lupin Ltd. will be licensed ...rcumstances. , , Lupin had earlier filed a P...
...differently,than men. That,s why Ft. Bragg, CA-bas...e nation,s first mattress specifically for women. ...itively recognizes the,difference between straight...bone structure is different," continues Turner. "...
...sa was only two when he became an orphan after bot... , After their death, Musa first went to live wi... his Aunt Hadija. Although too young to fully unde...S. And with each passing year, these children begi...
Other Medicine News:Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 2Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 3Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 4Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 5Health News:Independent Audit of Global Child Immunizations Urged 2Health News:Sex difference on spatial skill test linked to brain structure 2Health News:Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R) 2Health News:FloBeds Develops Nation's First 'For Women Only' Mattress 2Health News:CCF Connects Parents With Their Children Through the Power of a Memory 2
(Date:12/3/2009)...Pa., Dec. 3 Radiology imaging lead...d integration capabilities at the November 2009 Ra... Connect.PACS(TM) product, enabling the first rad...e latest release in the company,s newly branded C... http://www.newscom.com/cgi-bin/prnh/20091203/NE...
(Date:12/3/2009)... In response to the incr...echnologies in the evolving healthcare delivery sy...r Health Informatics (DCHI) to provide a campus fo...nnovative interdisciplinary approach to education ...nurses and healthcare administrators with an exper...
(Date:12/3/2009)... Apnex Medical, Inc., a private me...ted a second round of private equity financing tot...ete a clinical study and develop a second generati...ned to treat obstructive sleep apnea (OSA). ,, ...iates, New Enterprise Associates (NEA), Polaris Ve...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 1InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 2InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1
...s Corporation (Nasdaq: DVAX ) today reported that...weed allergy therapy, to subjects as,part of an en...d to enroll,a total of 300 subjects. Subjects are ...gy and a positive skin test. Exposure to ragweed a...se individuals with confirmed,ragweed allergic dis...
...nsistently Positive Clinical ...ta presented today from,Abbott,s SPIRIT III U.S. p...ive, statistically significant clinical results fo...nt System at one year, including continued,clinica...E) and continued,non- inferior rates of target ves...
Other Medicine Technology:Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5
House Teflon Coated Elevator
Cleft Palate Elevator
Louisville Elevator
Converse Periosteal Elevator
Medicine Products: